Use of biogenic estrogen sulfamates for hormone replacement therapy

摘要

Described is the use of biogenic estrogen sulfamates for the production of pharmaceutical agents for oral, intermittent administration for hormone replacement therapy, whereby the individual administrations have an interval of 2 to 40 days.